Seized Drug Screening using the ACQUITY RDa Detector

Significance of the Topic

Seized drug screening plays a critical role in forensic and law enforcement laboratories by providing rapid, reliable identification of controlled substances. Traditional spot tests and thin‐layer chromatography (TLC) can indicate common narcotics, but often fail to detect novel psychoactive compounds or provide confirmatory data. High‐resolution accurate mass (HRAM) screening with the ACQUITY RDa Detector addresses these limitations by combining fast liquid chromatography, full‐scan mass spectrometry, and fragmentation data to offer both presumptive and retrospective identification in a single injection.

Objectives and Overview of the Study

The primary goal of this application note was to demonstrate a streamlined ‘‘dissolve, filter, dilute, and shoot’’ workflow for screening seized drug evidence using Waters’ ACQUITY RDa Detector. A ten‐minute UPLC‐MS analysis was developed on a custom library of 100 target compounds. The study highlights method performance for street samples, pharmacy pills, and unknown peaks, illustrating both targeted and discovery‐driven approaches.

Methodology and Used Instrumentation

Sample Preparation:

• Pill samples crushed (~1 mg) and dissolved in 1 mL ethanol.
• Filtered through 0.2 µm Teflon membrane and diluted 100× in 20 % methanol.
• Liquid samples directly diluted 100× in 20 % methanol.
• Injection volume: 10 µL; total run time: 10 minutes.

Chromatographic Conditions:

• System: ACQUITY UPLC I-Class PLUS FTN.
• Column: HSS T3, 1.8 µm, 2.1 × 100 mm at 45 °C.
• Mobile phase A: 5 mM ammonium formate, pH 3.0; B: acetonitrile with 0.1 % formic acid.
• Gradient elution at 0.5 mL/min.

Mass Spectrometry:

• Detector: ACQUITY RDa benchtop time‐of‐flight mass spectrometer.
• Ionization: ESI positive; desolvation at 550 °C; capillary voltage 0.8 kV.
• Acquisition: full scan with data‐independent fragmentation (50–2000 m/z at 10 Hz).
• Dynamic lockmass correction enabled.

Data Processing:

• Software: waters_connect v1.9.12 with customizable target library and Discovery toolkit for retrospective analysis.

Main Results and Discussion

The workflow successfully screened a street‐recovered baggie, presumptively identifying hydrocodone, lorazepam, and acetaminophen within ten minutes. Blank injections between samples confirmed no carryover. A pharmacy pill run against the 100‐compound library showed no hits, prompting use of the Discovery tool. An unknown peak at 2.19 min was matched to lamotrigine via accurate mass, elemental formula prediction, and in silico fragmentation against ChemSpider databases. This presumptive identification was achieved from a single injection and minimal additional analyst time.

Retrospective data mining is enabled by full‐scan acquisition, allowing reevaluation of past injections when new targets arise, without repeat analyses.

Benefits and Practical Applications of the Method

• Rapid screening: 10‐minute analysis supports high throughput in forensic casework.
• High confidence: accurate mass, retention time, and fragmentation reduce false positives.
• Customizable library: easy updating to include emerging psychoactives.
• Retrospective analysis: full data capture facilitates post hoc identification of unknowns.

Future Trends and Opportunities

A shift toward broader target lists and integration with automated reporting could further enhance laboratory efficiency. Machine‐learning algorithms applied to fragmentation data may improve presumptive identification of novel substances. Miniaturization of HRAM instruments could enable field‐deployable screening. Additionally, expanding spectral libraries and interoperability with public databases will strengthen forensic intelligence.

Conclusion

The ACQUITY RDa Detector combined with UPLC delivers a robust, high‐throughput platform for presumptive forensic drug screening. Its accurate mass capability, customizable libraries, and full‐scan fragmentation enable confident identification and retrospective analysis, outperforming traditional color tests and TLC. Adoption of this workflow can streamline case processing and support forensic laboratories in tackling emerging drug threats.

References

No additional literature references provided in the source document.